/wp-content/uploads/2019/10/A-Randomized-Double-Blind-Phase-2-Study-of-Combination-Antivirals-for-the-Treatment-of-Influenza.pdf
Efficacy and Safety of Nitazoxanide in Addition to Standard of Care for the Treatment of Severe Acute Respiratory Illness
/wp-content/uploads/2019/10/Efficacy-and-Safety-of-Nitazoxanide-in-Addition-to-Standard-of-Care-for-the-Treatment-of-Severe-Acute-Respiratory-Illness.pdf
Differential human antibody repertoires following Zika infection and the implications for serodiagnostics and disease outcome
/wp-content/uploads/2019/10/Differential-human-antibody-repertoires-following-Zika-infection-and-the-implications-for-serodiagnostics-and-disease-outcome.pdf
Clinical characteristics of asthmatic patients with influenza-like illness and risk of severe exacerbations in Mexico
/wp-content/uploads/2019/09/Clinical-characteristics-of-asthmatic-patients-with-influenza-like-illness.pdf
Underweight, overweight, and obesity as independent risk factors for hospitalization in adults and children from influenza and other respiratory viruses
/wp-content/uploads/2019/09/Underweight-overweight-and-obesity-as-independent-risk.pdf
Epidemiology and clinical characteristics of respiratory syncytial virus infections among children and adults in Mexico
/wp-content/uploads/2019/09/Epidemiology-and-clinical-charachteristics-of-respiratory-syncytial-virus-infections-among-children-and-adults-in-Mexico.pdf